Gyurkocza B, Nath R, Seropian S, Choe H, et al. Randomized Phase III SIERRA Trial of (131)I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML. J Clin Oncol 2025;43:201-213.
PMID: 39298738